서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 11 of 11

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2007-11	Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives Kim, Toe-You; Han, Soe-Won; Bang, Yung-Jue Expert Review of Molecular Diagnostics, Vol.7 No.6, pp.821-836	DOI
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2010-06	Cancer prevention with natural compounds Collett, Norleena P.; Amin, A. R. M. Ruhul; Bayraktar, Soley; Pezzuto, John M.; Shin, Dong M.; Khuri, Fadlo R.; Aggarwal, Bharat B.; Surh, Young-Joon; Kucuk, Omer Seminars in Oncology, Vol.37 No.3, pp.258-281	DOI
2011-03	Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization Paik, Jin Ho; Choe, Gheeyoung; Kim, Hyojin; Choe, Ji-Young; Lee, Hyun Ju; Lee, Choon-Taek; Lee, Jong Seok; Jheon, Sanghoon; Chung, Jin-Haeng Journal of Thoracic Oncology, Vol.6 No.3, pp.466-472	DOI
2011-04	Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study Lim, Robert; Sun, Yan; Im, Seock-Ah; Hsieh, Ruey-Kuen; Yau, Tsz Kok; Bonaventura, Anthony; Cheirsilpa, Arkom; Esser, Regina; Mueser, Matthias; Advani, Suresh World Journal of Gastroenterology, Vol.17 No.14, pp.1879-1888	DOI
2012-06	Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma Paik, Jin Ho; Choi, Chang-Min; Kim, Hyojin; Jang, Se Jin; Choe, Gheeyoung; Kim, Dong Kwan; Kim, Hwa Jung; Yoon, Hoil; Lee, Choon-Taek; Jheon, Sanghoon; Choe, Ji-Young; Chung, Jin-Haeng Lung Cancer, Vol.76 No.3, pp.403-409	DOI
2012-12	The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Song, Sang-Hyun; Min, Ah-Rum; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.6, pp.2148-2160	DOI
2014-12	Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score Lee, Dae-Won; Shin, Dong-Yeop; Kim, Jin Wook; Keam, Bhumsuk; Kim, Tae Min; Kim, Hak Jae; Kim, Dong-Wan; Wu, Hong-Gyun; Paek, Sun Ha; Kim, Young Whan; Heo, Dae Seog; Kim, Dong Gyu; Lee, Se-Hoon Lung Cancer, Vol.86 No.3, pp.363-368	DOI
2016-02	Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02) Lee, Ji Yun; Xu Qing; Wei Xiumin; Bai Yali; Chi, Sangah; Bak, So Hyeon; Lee, Ho Yun; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Cho, Eun Kyung; Kim, Dong-Wan; Kim, Hye Ryun; Min, Young Joo; Jung, Sin-Ho; Park, Keunchil; Mao Mao; Ahn, Myung-Ju Oncotarget, Vol.7 No.6, pp.6984-6993	view file DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI

1